Basal cell carcinoma is uncontrolled and abnormal growth that occur in basal cells of the lower epidermis. It occur because of overexposure to ultraviolet rays. Drugs and surgery are major treatment option used for basal cell carcinoma.
𝗟𝗶𝗺𝗶𝘁𝗲𝗱 𝗧𝗶𝗺𝗲 𝗢𝗳𝗳𝗲𝗿!
𝗕𝘂𝘆 𝗡𝗼𝘄 𝗧𝗼 𝗔𝘃𝗮𝗶𝗹 𝗙𝗹𝗮𝘁 𝟯𝟬% 𝗢𝗙𝗙
Key Market Drivers:
Growing prevalence of skin malignancies is fostering growth of the basal cell carcinoma market. According to American Cancer Society, about 5.4 million basal and squamous cell skin cancers are diagnosed each year in the US (occurring in about 3.3 million Americans, as some people have more than one). About 8 out of 10 of these are basal cell cancers. Squamous cell cancers occur less often.
Increasing launch of new drug for improving treatment rate is again projected to foster growth of the market. For instance, in February 2021, The U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo® (cemiplimab-rwlc) as the first immunotherapy indicated for patients with advanced basal cell carcinoma (BCC) previously treated with a hedgehog pathway inhibitor (HHI) or for whom an HHI is not appropriate.
Covid-19 Impact Analysis
The outbreak of COVID-19 pandemic has badly affected several clinical trials. Moreover, government has introduced various guidelines for conducting clinical trials. This has posed numerous challenges associated with the clinical studies.
- The basal cell carcinoma market is expected to exhibit a CAGR of 7.9 % over the forecast period owing to the increasing prevalence of basal cell carcinoma and advancement in the treatment process.
- North America is expected to experience significant growth over the forecast period owing to the strong presence of healthcare industry and technological advancement in the region.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4794
Major Players Are: Merck & Co., Inc., Sun Pharmaceutical Industries Ltd., Novartis AG., Bausch & Lomb Incorporated., Allergan, Perrigo Company plc, Taro Pharmaceutical Industries Ltd., Provectus Biopharmaceuticals, Inc., F. Hoffmann-La Roche Ltd, Sanofi, and Mylan N.V.
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Basal Cell Carcinoma Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Basal Cell Carcinoma Industry Impact
Chapter 2 Global Basal Cell Carcinoma Competition by Types, Applications, and Top Regions and Countries
2.1 Global Basal Cell Carcinoma (Volume and Value) by Type
2.3 Global Basal Cell Carcinoma (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Basal Cell Carcinoma Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Basal Cell Carcinoma Market Analysis
Chapter 6 East Asia Basal Cell Carcinoma Market Analysis
Chapter 7 Europe Basal Cell Carcinoma Market Analysis
Chapter 8 South Asia Basal Cell Carcinoma Market Analysis
Chapter 9 Southeast Asia Basal Cell Carcinoma Market Analysis
Chapter 10 Middle East Basal Cell Carcinoma Market Analysis
Chapter 11 Africa Basal Cell Carcinoma Market Analysis
Chapter 12 Oceania Basal Cell Carcinoma Market Analysis
Chapter 13 South America Basal Cell Carcinoma Market Analysis
Chapter 14 Company Profiles and Key Figures in Basal Cell Carcinoma Business
Chapter 15 Global Basal Cell Carcinoma Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027